Evidence map›Paper›PMID 37151587›Full record

ArticleFrontiers in public health2023

Monitoring of indoor bioaerosol for the detection of SARS-CoV-2 in different hospital settings.

Emma Tedeschini, Stefania Pasqualini, Carla Emiliani, Ettore Marini, Alessandro Valecchi, Chiara Laoreti, Stefano Ministrini, Barbara Camilloni, Roberto Castronari, Lucio Patoia and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Emma TedeschiniDipartimento di Scienze Agrarie, Alimentari e Ambientali, Università degli Studi di Perugia, Perugia, Italy.
Stefania PasqualiniDipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi di Perugia, Perugia, Italy.
Carla EmilianiDipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi di Perugia, Perugia, Italy.
Ettore MariniDipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy.
Alessandro ValecchiDipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy.
Chiara LaoretiDipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy.
Stefano MinistriniDipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy.
Barbara CamilloniDipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy.
Roberto CastronariDipartimento di Medicina e Chirurgia, Università degli Studi di Perugia, Perugia, Italy.
Lucio PatoiaOspedale S.G. Battista - Azienda Unità Sanitaria Umbria 2, Foligno, Italy.
Francesco MeranteOspedale S.G. Battista - Azienda Unità Sanitaria Umbria 2, Foligno, Italy.
Stefano BaglioniS.C. Pneumologia, Ospedale Santa Maria della Misericordia, Azienda Ospedaliera di Perugia, Perugia, Italy.
Edoardo De RobertisDipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi di Perugia, Perugia, Italy.
Matteo PirroDipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi di Perugia, Perugia, Italy.
Antonella MencacciDipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi di Perugia, Perugia, Italy.
Leonella PasqualiniDipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi di Perugia, Perugia, Italy.
University of Perugia · ITAzienda Ospedaliero Universitaria San Giovanni Battista · ITAzienda Ospedaliera di Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Spore Trap is an environmental detection technology, already used in the field of allergology to monitor the presence and composition of potentially inspirable airborne micronic bioparticulate. This device is potentially suitable for environmental monitoring of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in hospital, as well as in other high-risk closed environments. The aim of the present study is to investigate the accuracy of the Spore Trap system in detecting SARS-CoV-2 in indoor bioaerosol of hospital rooms. Methods: The Spore Trap was placed in hospital rooms hosting patients with documented SARS-CoV-2 infection ( Results: The estimated sensitivity of the Spore Trap device for detecting SARS-CoV-2 in an indoor environment is 69.4% (95% C.I. 54.3-84.4%), with a specificity of 100%. Conclusion: The Spore Trap technology is effective in detecting airborne SARS-CoV-2 virus with excellent specificity and high sensitivity, when compared to previous reports. The SARS-CoV-2 pandemic scenario has suggested that indoor air quality control will be a priority in future public health management and will certainly need to include an environmental bio-investigation protocol.

Indexed as

COVID-19SARS-CoV-2HospitalizationHospitalsHumansPandemicsaerobiologybioaerosolenvironmental monitoringenvironmental preventionSARS-CoV-2

Identifiers

PMID37151587
PMCPMC10157290
OpenAlexW4366595353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.